BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Testicular cancer AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB
51 results:

  • 1. Hypomethylation-driven AKT Serine/Threonine Kinase 3 promotes testicular germ cell tumors proliferation and negatively correlates to immune infiltration.
    Luo Y; Zhou Q; Zhu F; Fan L; Bo H; Wang X
    Bioengineered; 2021 Dec; 12(2):11288-11302. PubMed ID: 34882061
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Recent Understanding and Future Directions of Recurrent Corticotroph Tumors.
    Hinojosa-Amaya JM; Lam-Chung CE; Cuevas-Ramos D
    Front Endocrinol (Lausanne); 2021; 12():657382. PubMed ID: 33986726
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive cancers.
    Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
    Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
    Mezei G; Chang ET; Mowat FS; Moolgavkar SH
    Scand J Work Environ Health; 2021 Jan; 47(1):85-86. PubMed ID: 32626907
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Longitudinal kidney function outcome in aging testicular cancer survivors.
    Nome RV; Cvancarova Småstuen M; Bjøro T; Kiserud CE; Fosså SD
    Acta Oncol; 2020 Apr; 59(4):467-474. PubMed ID: 32043400
    [No Abstract]    [Full Text] [Related]  

  • 6. Frequent egfr expression/egfr amplification and lack of activating mutation in testicular choriocarcinoma.
    Miyai K; Ito K; Matsukuma S; Tsuda H
    Pathol Int; 2020 May; 70(5):262-269. PubMed ID: 31994813
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Outcome Definition Influences the Relationship Between Genetic Polymorphisms of
    Zazuli Z; Otten LS; Drögemöller BI; Medeiros M; Monzon JG; Wright GEB; Kollmannsberger CK; Bedard PL; Chen Z; Gelmon KA; McGoldrick N; Kitchlu A; Vijverberg SJH; Masereeuw R; Ross CJD; Liu G; Carleton BC; Maitland-van der Zee AH
    Genes (Basel); 2019 May; 10(5):. PubMed ID: 31083486
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Carboplatin Dosing Accuracy by Estimation of Glomerular Filtration versus Creatinuria in cancer Patients.
    Graciano Vera N; Pino Villarreal L; Ureña Vargas J
    Chemotherapy; 2018; 63(3):137-142. PubMed ID: 29768260
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell Tumors.
    Chen KS; Fustino NJ; Shukla AA; Stroup EK; Budhipramono A; Ateek C; Stuart SH; Yamaguchi K; Kapur P; Frazier AL; Lum L; Looijenga LHJ; Laetsch TW; Rakheja D; Amatruda JF
    Mol Cancer Ther; 2018 May; 17(5):1079-1089. PubMed ID: 29483210
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Possible risk of overestimation of renal function using cystatin C-based egfr in testicular cancer survivors treated with cisplatin-based chemotherapy.
    Ichioka D; Kawai K; Tanaka K; Ishitsuka R; Yoshino T; Kimura T; Kandori S; Kawahara T; Kojima T; Usui J; Yamagata K; Miyazaki J; Nishiyama H
    Clin Exp Nephrol; 2018 Jun; 22(3):727-734. PubMed ID: 28948387
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Efficacy of targeted drugs in germ cell cancer cell lines with differential cisplatin sensitivity.
    Schaffrath J; Schmoll HJ; Voigt W; Müller LP; Müller-Tidow C; Mueller T
    PLoS One; 2017; 12(6):e0178930. PubMed ID: 28591197
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumours.
    Sanmamed MF; Esteban E; Uriol E; Zarate R; Capelan M; Muriel C; Crespo G; Berros JP; Pardo-Coto P; Perez Q; Alvarez-Fernández C; Jiménez Fonseca P; Luque M; Astudillo A
    J Transl Med; 2017 Mar; 15(1):62. PubMed ID: 28320414
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anticancer activity of drug conjugates in head and neck cancer cells.
    Majumdar D; Rahman MA; Chen ZG; Shin DM
    Front Biosci (Elite Ed); 2016 Jun; 8(3):358-69. PubMed ID: 27100344
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Effects of bleomycin and antioxidants on the fatty acid profile of testicular cancer cell membranes.
    Cort A; Ozben T; Melchiorre M; Chatgilialoglu C; Ferreri C; Sansone A
    Biochim Biophys Acta; 2016 Feb; 1858(2):434-41. PubMed ID: 26656160
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Next generation sequencing analysis of platinum refractory advanced germ cell tumor sensitive to Sunitinib (Sutent®) a Vegfr2/PDGFRβ/c-kit/ FLT3/RET/CSF1R inhibitor in a phase II trial.
    Subbiah V; Meric-Bernstam F; Mills GB; Shaw KR; Bailey AM; Rao P; Ward JF; Pagliaro LC
    J Hematol Oncol; 2014 Aug; 7():52. PubMed ID: 25085632
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Reliability of estimated glomerular filtration rate in patients treated with platinum containing therapy.
    Lauritsen J; Gundgaard MG; Mortensen MS; Oturai PS; Feldt-Rasmussen B; Daugaard G
    Int J Cancer; 2014 Oct; 135(7):1733-9. PubMed ID: 24585507
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Effectivity of pazopanib treatment in orthotopic models of human testicular germ cell tumors.
    Juliachs M; Vidal A; Del Muro XG; Piulats JM; Condom E; Casanovas O; Graupera M; Germà JR; Villanueva A; Viñals F
    BMC Cancer; 2013 Aug; 13():382. PubMed ID: 23937707
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Does the number of cycles of cisplatin based chemotherapy have any effect on renal function in patients with testicular germ cell tumor?
    Suer E; Mermerkaya M; Gülpınar Ö; Afandiyev F; Baltacı S; Türkölmez K; Bedük Y
    J Urol; 2013 Dec; 190(6):2081-5. PubMed ID: 23764076
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. erbbs inhibition by lapatinib blocks tumor growth in an orthotopic model of human testicular germ cell tumor.
    Juliachs M; Castillo-Ávila W; Vidal A; Piulats JM; Garcia Del Muro X; Condom E; Hernández-Losa J; Teixidó C; Pandiella A; Graupera M; Casanovas O; Germà JR; Villanueva A; Viñals F
    Int J Cancer; 2013 Jul; 133(1):235-46. PubMed ID: 23292912
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERα36 induction.
    Wallacides A; Chesnel A; Ajj H; Chillet M; Flament S; Dumond H
    Mol Cell Endocrinol; 2012 Mar; 350(1):61-71. PubMed ID: 22138413
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.